This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
HealthdirectFree Australian health advice you can count on. — Description, Dosage, Side Effects | PillsCard
OTC
HealthdirectFree Australian health advice you can count on.
0.5MG, Tablet
INN: CABERGOLINE
Data updated: 2026-04-18
Available in:
🇬🇧🇫🇷🇵🇹
Form
TABLET
Dosage
0.5MG
Route
ORAL
Storage
—
About This Product
Manufacturer
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
INGENUS PHARMACEUTICALS LLC
ATC Code
G02CB03
Source
FDA_OB · 204735
(
ARTG
)
Inhibition of physiological lactation ,Cabergoline is indicated for the prevention of the onset of physiological lactation in the puerperium for clearly defined medical reasons. , Treatment of hyperprolactinaemic disorders ,Cabergoline is indicated for the treatment of pathological hyperprolactinaemia.
⚠️ Warnings
•Caution should be exercised in patients with history of heart disease, Raynaud's syndrome, liver or kidney impairment, peptic ulcer, gastrointestinal bleeding, history of psychosis, high blood pressure, during pregnancy and breastfeeding.
It may cause dizziness or drowsiness, do not drive a car or operate machinery while taking this medication.
Avoid prolonged use and/or usage of high doses otherwise it may lead to psychiatric disorders, heart or lung disorder.
Avoid alcohol consumption while taking this medication.
Monitor serum prolactin level monthly until normalization.